Table 1.

The clinicopathologic characteristics of the patients

Clinicopathologic factors	Number of patients (%)
Histologic type
Serous	140 (56.5)
Mucinous	47 (19.0)
Endometrioid	19 (7.7)
Clear	42 (16.9)
Residual tumor
Optimal	167 (90.8)
Suboptimal	17 (9.2)
Tumor grade
1	57 (23.0)
2	122 (49.2)
3	69 (27.8)
Tumor stage
Early	68 (37.2)
Advanced	115 (62.8)
Nuclear grade
Mild and moderate	137 (55.2)
Marked	111 (44.8)
Mitosis
0–9/10 HPFs	93 (37.5)
10–24/10 HPFs	95 (38.3)
> =25/10 HPFs	60 (24.2)
Chemoresponse
Regressive disease	73 (43.5)
Stable/progressive disease	95 (56.5)